Key safety measures including adverse events. by Anuja Dokras (8679261)

“…As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

Subjects:

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Three Ca_V3.3 variants left-shift the window current, while the A398V completely abolishes the window current. by Yousra El Ghaleb (22075892)

Two magnifications SEM images for the produced SiO₂ nanoparticles. by Nasser A. M. Barakat (11705885)

Subjects:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

Subjects:

XRD pattern for the prepared titanium oxide nanofibers. by Nasser A. M. Barakat (11705885)

Subjects:

Plasticity limit (%) of pristine and modified Egyptian kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Thermal gravimetric analyses and the first derivative for the obtained data for the PVA; (A and B) and TiO₂; (C and D) compared with the pristine kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Chemical composition (%) of the Egyptian clay [9]. by Nasser A. M. Barakat (11705885)

Subjects:

Compression strength of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Two magnifications SEM; (A and B) and TEM (C and D) images for the produced TiO₂ nanofibers. by Nasser A. M. Barakat (11705885)

Subjects:

Apparent density of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Water absorption of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

Subjects:

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. by Nasser A. M. Barakat (11705885)

Subjects:

Porosity of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects: